These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 38013718)

  • 1. Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis.
    Zhang X; Guo M; Huang Z; Huang Y; Wu C; Pan X
    Infect Med (Beijing); 2022 Jun; 1(2):103-112. PubMed ID: 38013718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
    Li L; Zhu C; Zhao X; Qu F
    Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis.
    Zhong H; Zhou Y; Mei SY; Tang R; Feng JH; He ZY; Xu QY; Xing SP
    Front Public Health; 2022; 10():967829. PubMed ID: 36203683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Patents and Advances on Nanotechnologies against Coronavirus.
    Abedini-Nassab R; Mahdaviyan N
    Recent Pat Nanotechnol; 2021; 15(4):322-330. PubMed ID: 33172382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-Based Strategies for the Management of COVID-19: Recent Developments and Challenges.
    Singh R; Behera M; Kumari N; Kumar S; Rajput VD; Minkina TM; Adnan M; Siddiqui AJ; Kumar N
    Curr Pharm Des; 2021; 27(41):4197-4211. PubMed ID: 34459371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bibliometric analysis of rheumatology and COVID-19 researches.
    Pasin O; Pasin T
    Clin Rheumatol; 2021 Nov; 40(11):4735-4740. PubMed ID: 34215906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global research trends in MERS-CoV: A comprehensive bibliometric analysis from 2012 to 2021.
    Ahmad T
    Front Public Health; 2022; 10():933333. PubMed ID: 35991022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.
    Rahman MM; Ahmed M; Islam MT; Khan MR; Sultana S; Maeesa SK; Hasan S; Hossain MA; Ferdous KS; Mathew B; Rauf A; Uddin MS
    Curr Pharm Des; 2022; 28(12):948-968. PubMed ID: 34218774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology-based strategies against SARS-CoV-2 variants.
    Huang X; Kon E; Han X; Zhang X; Kong N; Mitchell MJ; Peer D; Tao W
    Nat Nanotechnol; 2022 Oct; 17(10):1027-1037. PubMed ID: 35982317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bibliometric Analysis and Systematic Review of Global Coronavirus Research Trends Before COVID-19: Prospects and Implications for COVID-19 Research.
    Yan P; Li M; Li J; Lu Z; Hui X; Bai Y; Xun Y; Lao Y; Wang S; Yang K
    Front Med (Lausanne); 2021; 8():729138. PubMed ID: 34869424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development trends of human organoid-based COVID-19 research based on bibliometric analysis.
    Li M; Yuan Y; Zou T; Hou Z; Jin L; Wang B
    Cell Prolif; 2023 Dec; 56(12):e13496. PubMed ID: 37218396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global research trends at the intersection of coronavirus disease 2019 (COVID-19) and traditional, integrative, and complementary and alternative medicine: a bibliometric analysis.
    Ng JY
    BMC Complement Med Ther; 2020 Nov; 20(1):353. PubMed ID: 33225948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
    Milane L; Amiji M
    Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics.
    Ghaffari M; Mollazadeh-Bajestani M; Moztarzadeh F; Uludağ H; Hardy JG; Mozafari M
    Emergent Mater; 2021; 4(1):19-34. PubMed ID: 33426467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bibliometric Analysis of COVID-19 and the Association With the Number of Total Cases.
    Pasin O; Pasin T
    Disaster Med Public Health Prep; 2022 Oct; 16(5):1947-1952. PubMed ID: 34100348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bibliometric analysis of COVID-19 publications in neurology by using the visual mapping method.
    Zhang Q; Li J; Weng L
    Front Public Health; 2022; 10():937008. PubMed ID: 35958855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnologies for the Diagnosis and Treatment of SARS-CoV-2 and Its Variants.
    Park E; Choi SY; Kim J; Hildebrandt N; Lee JS; Nam JM
    Small Methods; 2023 Jul; 7(7):e2300034. PubMed ID: 37189215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative bibliometric analysis of Omicron and Delta variants during the COVID-19 pandemic.
    Liu YX; Wang LH; Zhu C; Zha QF; Yu YT
    Ann Palliat Med; 2023 Jan; 12(1):60-69. PubMed ID: 36571170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic.
    Rabiee N; Bagherzadeh M; Ghasemi A; Zare H; Ahmadi S; Fatahi Y; Dinarvand R; Rabiee M; Ramakrishna S; Shokouhimehr M; Varma RS
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.